Search results
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 3 days agoThe vaccine is based on protein technology, which is appealing to people hesitant to use the newer...
How Messenger RNA Made The COVID Vaccines Possible
Science Friday· 3 days agoThe following is an excerpt from The Catalyst: RNA and the Quest to Unlock Life’s Deepest Secrets by Thomas R. Cech. On January 10, 2020, Prof. Yong-Zhen Zhang of Fudan University in Shanghai ...
NHS England launches pioneering trials for world-first cancer vaccine
BioPharma-Reporter· 6 days agoTo date, thirty hospitals have joined NHS England's Cancer Vaccine Launch Pad, which aims to...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via Yahoo News· 6 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Colorado Springs Gazette· 4 days agoThe 16 advisors did not vote on whether to favor the original JN.1 variant or one of its successors...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 4 days agoNovavax shares have gained nearly 40% over the past five days, boosted by COVID-19 headlines....
COVID Shots for JN.1 Variant Neutralize Newer Strains, Vaccine Makers Say
US News & World Report· 4 days agoFood and Drug Administration's advisers on Wednesday. The FDA panel will vote to recommend if companies should target the JN.1 variant when the companies update their vaccines for 2024-25 immunization ...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 2 days agoOn Friday, Moderna Inc. MRNA announced that it has submitted an FDA application for review of its...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Colorado Springs Gazette· 6 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Colorado Springs Gazette· 2 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization recommendations and comes after the agency's advisers on Wednesday overwhelmingly backed the ...